- Home
- ACEL vs RCUS Comparison
ACEL vs RCUS Comparison
Compare ACEL & RCUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACEL
- RCUS
- Stock Information
- Founded
- ACEL 2009
- RCUS 2015
- Country
- ACEL United States
- RCUS United States
- Employees
- ACEL N/A
- RCUS N/A
- Industry
- ACEL Services-Misc. Amusement & Recreation
- RCUS Biotechnology: Pharmaceutical Preparations
- Sector
- ACEL Consumer Discretionary
- RCUS Health Care
- Exchange
- ACEL Nasdaq
- RCUS Nasdaq
- Market Cap
- ACEL 818.8M
- RCUS 727.1M
- IPO Year
- ACEL N/A
- RCUS 2018
- Fundamental
- Price
- ACEL $11.05
- RCUS $7.88
- Analyst Decision
- ACEL Strong Buy
- RCUS Strong Buy
- Analyst Count
- ACEL 2
- RCUS 10
- Target Price
- ACEL $16.00
- RCUS $29.50
- AVG Volume (30 Days)
- ACEL 521.8K
- RCUS 1.2M
- Earning Date
- ACEL 05-07-2025
- RCUS 05-07-2025
- Dividend Yield
- ACEL N/A
- RCUS N/A
- EPS Growth
- ACEL N/A
- RCUS N/A
- EPS
- ACEL 0.41
- RCUS N/A
- Revenue
- ACEL $1,230,972,000.00
- RCUS $258,000,000.00
- Revenue This Year
- ACEL $8.29
- RCUS N/A
- Revenue Next Year
- ACEL $4.28
- RCUS $25.77
- P/E Ratio
- ACEL $26.95
- RCUS N/A
- Revenue Growth
- ACEL 5.17
- RCUS 120.51
- 52 Week Low
- ACEL $9.02
- RCUS $6.50
- 52 Week High
- ACEL $12.96
- RCUS $18.98
- Technical
- Relative Strength Index (RSI)
- ACEL 60.99
- RCUS 44.26
- Support Level
- ACEL $9.02
- RCUS $6.75
- Resistance Level
- ACEL $10.89
- RCUS $8.36
- Average True Range (ATR)
- ACEL 0.41
- RCUS 0.60
- MACD
- ACEL 0.17
- RCUS 0.16
- Stochastic Oscillator
- ACEL 88.67
- RCUS 74.19
About ACEL Accel Entertainment Inc.
Accel Entertainment Inc is a distributed gaming and local entertainment operator in the United States. It is engaged in the installation, maintenance, operation, and servicing of gaming terminals and related equipment, redemption devices that disburse winnings and contain automated teller machine (ATM) functionality, and amusement devices in authorized non-casino locations such as restaurants, bars, taverns, convenience stores, liquor stores, truck stops, and grocery stores. The Company also operates stand-alone ATMs in gaming and non-gaming locations. It generates revenue from Net gaming, Amusement, Manufacturing, ATM fees, and others.
About RCUS Arcus Biosciences Inc.
Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.